Laura E Niklason insider trades: Humacyte (HUMA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Laura reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | HUMA | ↓ Sell | 2,241,045 | $1.67 | $3.7M | By Ayabudge LLC | Aug 20, 2025 (0d) |
| Nov 20, 2024 | HUMA | ↓ Sell | 1,500,000 | $4.40 | $6.6M | By Ayabudge LLC | Nov 20, 2024 (0d) |
| Nov 19, 2024 | HUMA | ↑ Buy | 1,797 | $4.44 | $8K | Direct | Nov 21, 2024 (2d) |
| Sep 10, 2024 | HUMA | ↓ Sell | 446,378 | $5.30 | $2.4M | By Ayabudge LLC | Sep 11, 2024 (1d) |
| Aug 29, 2024 | HUMA | ↑ Buy | 1,222 | $6.54 | $8K | Direct | Sep 3, 2024 (5d) |
| Aug 29, 2024 | HUMA | ↓ Sell | 881,878 | $6.49 | $5.7M | By Ayabudge LLC | Aug 29, 2024 (0d) |
| Jun 12, 2024 | HUMA | ↓ Sell | 630,148 | $7.17 | $4.5M | By Ayabudge LLC | Jun 13, 2024 (1d) |
| Jun 4, 2024 | HUMA | ↓ Sell | 1,001,852 | $7.82 | $7.8M | By Ayabudge LLC | Jun 4, 2024 (0d) |
| Jun 4, 2024 | HUMA | ↑ Buy | 2,362 | $6.35 | $15K | Direct | Jun 4, 2024 (0d) |
| Jun 3, 2024 | HUMA | ↑ Buy | 2,050 | $7.37 | $15K | Direct | Jun 3, 2024 (0d) |
| Sep 14, 2023 | HUMA | ↓ Sell | 2,000,000 | $2.78 | $5.6M | By Ayabudge LLC | Sep 15, 2023 (1d) |
| Aug 21, 2023 | HUMA | ↓ Sell | 1,799,596 | $3.54 | $6.4M | By Ayabudge LLC | Aug 21, 2023 (0d) |
| Jun 15, 2023 | HUMA | ↓ Sell | 500,000 | $3.12 | $1.6M | By Ayabudge LLC | Jun 16, 2023 (1d) |
| Jun 13, 2023 | HUMA | ↓ Sell | 4,875,000 | $2.60 | $12.7M | By Ayabudge LLC | Jun 15, 2023 (2d) |
| May 25, 2023 | HUMA | ↓ Sell | 2,625,000 | $2.75 | $7.2M | By Ayabudge LLC | May 26, 2023 (1d) |
| Dec 16, 2022 | HUMA | ↓ Sell | 239,538 | $2.53 | $606K | By Ayabudge LLC | Dec 19, 2022 (3d) |
| Dec 15, 2022 | HUMA | ↑ Buy | 10,000 | $2.54 | $25K | Direct | Dec 19, 2022 (4d) |
| Dec 15, 2022 | HUMA | ↓ Sell | 699,730 | $2.78 | $1.9M | By Ayabudge LLC | Dec 15, 2022 (0d) |
| Sep 15, 2022 | HUMA | ↓ Sell | 1,522,500 | $4.00 | $6.1M | By Ayabudge LLC | Sep 19, 2022 (4d) |
| Sep 15, 2022 | HUMA | ↑ Buy | 2,000 | $4.14 | $8K | Direct | Sep 19, 2022 (4d) |
| May 23, 2022 | HUMA | ↑ Buy | 10,000 | $4.83 | $48K | Direct | May 25, 2022 (2d) |
| Dec 16, 2021 | HUMA | ↓ Sell | 300,000 | $9.10 | $2.7M | By spouse | Dec 16, 2021 (0d) |
| Aug 26, 2021 | HUMA | ↑ Buy | 1,522,500 | $10.00 | $15.2M | By Ayabudge LLC | Aug 27, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HUMA insiders
Open-market trades in the last 12 months
About Laura E Niklason's insider trades
Laura E Niklason is President, CEO and Director at Humacyte (HUMA). Since Aug 26, 2021, Laura has reported 8 open-market purchases worth $15.4M and 15 sales worth $75.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (12 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HUMA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.